Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Honliv Healthcare Management Group Co Ltd ( (HK:9906) ) just unveiled an announcement.
Honliv Healthcare Management Group has announced the resignation of PricewaterhouseCoopers as its auditor, effective 24 March 2026, after the discovery of an unrecorded RMB63 million bank loan and related payments during the audit of its 2025 financial statements. PwC indicated it lacked sufficient information to complete necessary audit procedures, leading the board to cease providing further materials and to request the firm’s resignation, which may delay the publication of the 2025 annual results.
In response, the company’s audit committee has formed an independent investigation committee comprising its independent non-executive directors to review the unrecorded loan and associated matters. The committee has engaged an independent accounting firm and legal advisors in both mainland China and Hong Kong to define the investigation’s scope, handle regulatory issues, and assess the implications for the group’s financial reporting and governance practices.
The most recent analyst rating on (HK:9906) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Honliv Healthcare Management Group Co Ltd stock, see the HK:9906 Stock Forecast page.
More about Honliv Healthcare Management Group Co Ltd
Honliv Healthcare Management Group Company Limited is a healthcare services provider listed on the Hong Kong Stock Exchange. The group operates through subsidiaries in mainland China, focusing on medical and hospital management services under a Cayman Islands holding structure.
Average Trading Volume: 19,500
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$936M
See more insights into 9906 stock on TipRanks’ Stock Analysis page.